Search Results

What I Wish I Learned in Fellowship…

Physicians consider the aspects of interventional cardiology that would benefit from more comprehensive coverage in training, sharing ideas for how next-generation interventional cardiologists can take full advantage of their training programs.

With Michael N. Young, MD, FACC, FSCAI, RPVI; Mina Iskander, MD, MSc; Babar Basir, DO, FACC, FSCAI; Boskey Patel, DO, FACC; and Aditya Bharadwaj, MD, FACC, FSCAI

Preparing Health Systems for Broader TAVR Access

A three-pillar framework for diagnostics, clinical workflows, and operational planning to support expanding TAVR eligibility.

By Sumit R. Kumar, MD, MPA; Natalia C. Berry, MD, MBA, FACC; James T. DeVries, MD, FACC; Henry J. Tannous, MD; and Michael N. Young, MD, FACC, FSCAI, RPVI

Evolving TAVR Paradigms

By Suzanne J. Baron, MD, MSc

Device Closure for PFO

The data and devices associated with percutaneous PFO closure.

By Gerald Yong, MBBS (Hons), FRACP; Michael H. Salinger, MD, FACC, FSCAI; and Ted E. Feldman, MD, FACC, FSCAI

PFO Closure to Prevent Recurrent TIA and Stroke

What is the evidence base for patent foramen ovale closure?

By Michael H. Salinger, MD, FACC, FSCAI; Mehmet Cilingiroglu, MD, FACC, FESC, FSCAI; Justin P. Levisay, MD, FACC, FSCAI; and Ted E. Feldman, MD, FACC, FESC, FSCAI

Alcohol Septal Ablation

Patient selection, preprocedural planning, a step-by-step procedural overview, and postprocedural management tips for performing septal reduction therapy using alcohol septal ablation in HCM patients with LVOT obstruction.

By Michael Ragosta, MD

Management of No Reflow and Thrombus

A panel of experts share clinical scenarios, treatment approaches, challenges, and more.

With Jasleen Tiwana, MD; Blake Charlton, MD, FACC, FSCAI; Jesse A. Kane, MD; and Kalaivani Mahadevan, MD